Please check your internet connection and try again.
# Ecospirin 250mg Enteric-Coated Aspirin
## Overview
Ecospirin is an enteric-coated aspirin product. Aspirin is a nonsteroidal anti-inflammatory drug (NSAID) with analgesic, antipyretic, and antiplatelet properties. The enteric coating is designed to delay absorption until the drug reaches the small intestine, which may reduce gastric irritation.
## Primary Indications
* **Pain and Fever:** Mild to moderate pain (headache, muscle aches, toothaches) and fever.
* **Antiplatelet Therapy:** Prevention of thrombotic events (e.g., myocardial infarction, stroke) in patients with established cardiovascular disease or specific risk factors. This is often referred to as low-dose aspirin therapy.
## Adult Dosing
* **Pain and Fever:**
* 250 mg to 1000 mg every 4 to 6 hours as needed.
* Maximum daily dose: Typically 4000 mg, but lower limits may be advised based on individual risk factors and formulation.
* **Antiplatelet Therapy (Prophylaxis):**
* 75 mg to 325 mg once daily. The specific dose depends on the indication and concurrent therapies.
## Pediatric Dosing
* **Pain and Fever:**
* Dosing is typically based on weight: 10 mg/kg to 15 mg/kg per dose, every 4 to 6 hours.
* Maximum single dose: 650 mg.
* **Important Note:** Aspirin is **contraindicated** in children and teenagers with viral infections (including influenza and varicella) due to the risk of Reye's syndrome.
## Dose Adjustments
* **Renal Impairment:** Use with caution. Higher doses may require adjustment based on renal function.
* **Hepatic Impairment:** Use with caution.
* **Elderly:** Increased risk of gastrointestinal bleeding, renal toxicity, and hypersensitivity reactions; consider lower doses.
## Contraindications
* Known hypersensitivity to aspirin, salicylates, or NSAIDs.
* Children and teenagers with viral infections.
* Active peptic ulcer disease or a history of recurrent ulcers.
* Bleeding disorders (e.g., hemophilia, thrombocytopenia).
* Severe hepatic or renal impairment.
* Late pregnancy (third trimester).
## Adverse Effects
* **Common:** Gastrointestinal upset (nausea, vomiting, dyspepsia), heartburn.
* **Serious:**
* Gastrointestinal bleeding and ulceration.
* Hemorrhagic stroke.
* Tinnitus (ringing in the ears) and hearing loss (especially at higher doses).
* Hypersensitivity reactions (asthma exacerbation, urticaria, angioedema).
* Renal impairment.
* Reye's syndrome in children/teenagers with viral infections.
## Key Drug Interactions
* **Anticoagulants (e.g., Warfarin, DOACs):** Increased risk of bleeding.
* **Other NSAIDs and Corticosteroids:** Increased risk of gastrointestinal bleeding.
* **Antihypertensives (e.g., ACE inhibitors, ARBs, beta-blockers):** Aspirin may reduce their efficacy.
* **Methotrexate:** Aspirin may increase methotrexate toxicity.
* **Selective Serotonin Reuptake Inhibitors (SSRIs):** Increased risk of bleeding.
* **Uricosuric agents (e.g., probenecid):** Aspirin may decrease their efficacy.
## Monitoring
* Signs and symptoms of gastrointestinal bleeding (melena, hematochezia, abdominal pain).
* Signs and symptoms of hypersensitivity.
* Renal function (especially in patients with pre-existing renal disease or those taking other nephrotoxic agents).
* Platelet function if antiplatelet therapy is a primary indication.
* Tinnitus or hearing changes, which can indicate salicylate toxicity.
## Clinical Pearls
* The enteric coating delays onset of action and may reduce gastric irritation but does not eliminate the risk of gastrointestinal bleeding. Taking with food or milk may further reduce minor GI upset.
* For antiplatelet therapy, consistent daily dosing is crucial.
* Discontinue aspirin at least 5-7 days prior to elective surgery, depending on the surgical procedure and bleeding risk.
* Salicylate toxicity can manifest as tinnitus, confusion, hyperventilation, and metabolic acidosis.
***
*This information is intended for healthcare professionals and is not a substitute for professional medical advice. Always consult the most current prescribing information and relevant clinical guidelines before making any treatment decisions.*
